¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò : 2023-11-25
±³À°ÀÏÀÚ : 2023-11-25
±³À°Àå¼Ò : À¯ÇѾçÇà º»»ç °´ç
±³À°ÁÖÁ¦ : ¾ËÄڿÿ¬±¸È¸ ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾËÄڿÿ¬±¸È¸
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091
À̸ÞÀÏ : kasl@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 13:10~13:30 Role of PDH regulation in alcoholic hepatitis ÀÌÀαÔ(°æºÏ´ë ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 13:30~13:50 The impacts of binge alcohol drinking: multiple mechanisms of SLD ¼¿øÈ¿(ÀÌÈÀÇ´ë ¾à´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 13:50~14:10 Exploring the contribution of mitochondrial quality control factors in pathogenesis of steatotic liver diseases ±è½ÂÁø(°¿ø´ë ÀÚ¿¬´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 14:10~14:30 Role of CXCL1 in the experimental models of MASLD and MetALD Ȳ¼ºÈ¯(ºÎ»ê´ë ¾à´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 14:50~15:10 SLD: The new nomenclature consensus updates À±ÀçÇö(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 15:10~15:30 Impact of alcohol consumption and metabolic syndrome on liver-related outcomes ±è¹ü°æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 15:30~15:50 Impact of alcohol consumption on extrahepatic outcomes ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 16:10~16:30 The effect of metabolic risk factor on long-term adverse outcom in prospective KaCLiF cohort ÀÓÁöÇý(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 16:30~16:50 Different risk factors of clinical outcomes between variceal bleeding and non-variceal gastrointestinal bleeding in acutely decompensated cirrhosis ¹ÚÁö¿ø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 16:50~17:10 The Association between Alcohol Consumption and the Risk of Hepatocellular Carcinoma according to Glycemic Status Á¶ÀºÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 25ÀÏ À¯ÇѾçÇà º»»ç °´ç 17:10~17:30 prospecitve KaCLiF/ARCADE ±è¼ºÀº(ÇѸ²ÀÇ´ë)